The Centers for Medicare & Medicaid Services yesterday released a request for applications to participate in the Part D Payment Modernization Model in calendar year 2022.

The five-year model, which began this month, will test new incentives for Medicare prescription drug plans, patients and providers to choose drugs with lower list prices. For CY 2022, CMS said the model will test new flexibilities to better align Part D formularies with other pharmacy benefit designs in the commercial and individual markets, and remove the model’s downside risk.

Interested Part D sponsors should submit a non-binding notice of intent to apply by March 1 and an application by April 16, 2021.

Related News Articles

Headline
The AHA Jan. 31 commended Sens. Bill Cassidy, R-La., Catherine Cortez Masto, D-Nev., John Cornyn, R-Texas., and Michael Bennet, D-Colo., on draft legislation…
Headline
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
An analysis by KFF released Jan. 28 found that Medicare Advantage insurers made nearly 50 million prior authorization determinations in 2023. The finding…
Headline
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
The AHA Jan. 27 voiced support for the Centers for Medicare & Medicaid Services proposed rule on policy and technical changes to Medicare Advantage and…
Headline
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations. Negotiations will…